Larimar Therapeutics, Inc. logo LRMR - Larimar Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 8
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $12.00 DETAILS
HIGH: $12.00
LOW: $12.00
MEDIAN: $12.00
CONSENSUS: $12.00
UPSIDE: 247.83%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 2.19
Quick Ratio 2.19
Solvency Ratio -2.440
Cash Ratio 1.32

Valuation Ratios

Ratio Value
Price/Earnings
-1.68
Peers avg: 4.5
PEG Ratio -0.02
Forward PEG -0.02
Price/Book 3.56
Price/Sales 0.00
Price/FCF -2.45
Price/Op Cash Flow -2.46

Debt Ratios

Ratio Value
Debt/Assets 0.0279
Debt/Equity 0.0521
Debt/Capital 0.0495
Long-Term Debt/Capital 0.0000
Financial Leverage 1.87

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -1.747
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.1%

Coverage Ratios

Ratio Value
Debt Service Coverage -155.79
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -102.44
Operating Cash Flow Coverage -27.83
Capital Expenditure Coverage -1243.97
Dividend + Capital Expenditure Coverage -1243.97

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -2.271
Debt/Share 0.0558
Cash/Share 1.88
Book Value/Share 1.07
Tangible BV/Share 1.07
Equity/Share 1.07
Operating Cash Flow/Share -1.552
Capital Expenditure/Share 0.001
FCF/Share -1.553

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.960
Price/Fair Value 3.56
Debt/Market Cap 0.0040
Effective Tax Rate 0.0%
Enterprise Value Multiple -1.14